COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Oklahoma patients with a documented clinical need may be eligible for compounded tirzepatide.
Oklahoma has significant diabetes and obesity rates. Healthcare is centered in Oklahoma City and Tulsa, with rural areas having fewer options. Compounding Finder helps Oklahoma residents compare licensed pharmacies.
Yes. The Oklahoma State Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.
.png){kind=spacer}
